A GHRH analogue and one of the longest-standing tools in growth-hormone research.
Improved sleep quality; better recovery; increased energy and vitality; gradual lean-mass gains; reductions in body fat (especially visceral) with consistent use.
Was FDA-approved as Geref for paediatric growth hormone deficiency at a weight-based dose, withdrawn from the US market in 2009 - not for safety or efficacy reasons. Today's flat adult dose is compounding-pharmacy convention for an indication it was never approved for.
No reference figure is given here. There is no personal reference on file for this compound, and we would rather leave it blank than fill it with a guess. The calculator will do the arithmetic for any amount you enter.
| Sermorelin | 1 mL water | 2 mL water | 3 mL water | 5 mL water |
|---|---|---|---|---|
| 5 mg vial | 5,000 mcg/mL | 2,500 mcg/mL | 1,667 mcg/mL | 1,000 mcg/mL |
| One unit (0.01 mL) | 50 mcg | 25 mcg | 17 mcg | 10 mcg |
Concentration = vial contents ÷ water added. It is the same compound at every volume — more water only means a weaker solution, larger syringe marks that are easier to read, and a larger injection volume. On a standard U-100 insulin syringe, one unit is 0.01 mL at any barrel size.
Education only. This page is educational. Most compounds referenced are not approved for human use, and a "research use only" label carries no legal status of its own.
Reported, not established. Any figure shown is a reported personal reference at the reconstitution stated — not a community average, not a clinical dose, and not necessarily right for anyone else's body, goals, or product.
Blank is deliberate. Where no figure appears, there is no personal reference to give. We would rather say nothing than imply confidence that isn't there.
Not medical advice. Nothing here constitutes medical advice, diagnosis, or treatment. Several of these are prescription medicines in Canada and the US, and several are approved nowhere at all. Consult a qualified healthcare professional before beginning any protocol.